洁特生物(688026) - 2024 Q2 - 季度业绩预告

Financial Performance - The company achieved a net profit attributable to the parent company of 30.5 million yuan, an increase of 27.54 million yuan, representing a year-on-year increase of 929.77%[9] - The expected operating revenue is 230 million yuan, an increase of 33.35 million yuan, which is a year-on-year increase of 16.96%[14] - The net profit attributable to the parent company after deducting non-recurring gains and losses is expected to be 26 million yuan, an increase of 25.24 million yuan, representing a year-on-year increase of 3310.37%[2] - The company reported an operating revenue of 196.65 million yuan for the first half of 2024[10] Profitability and Cost Control - The company reported a significant increase in gross profit margin compared to the same period last year, with a substantial improvement from the first quarter to the second quarter[1] - The company has effectively controlled raw material prices despite rapid market price increases, contributing to improved profitability[1] - The company is actively promoting automation upgrades to reduce production costs and control expenses[1] Business Strategy - The company is focusing on expanding its product line and enhancing product quality to maintain customer recognition and attract new clients[1] Legal Matters - The company has ongoing significant litigation with a total amount involved of 39.65 million yuan, which may impact future profits[11] Financial Reporting - The financial data presented is preliminary and subject to final confirmation by the company's financial department[6]